← Evidence map

TrialHaematologica2010

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial.

Antonio Palumbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this paperpooled itcites it

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial. | OpenQuestion